To enable the adoption of drug-target binding kinetics analysis in the drug discovery decision-making process, and thereby contribute to the development of a new generation of improved medicinal products


Early and improved prediction of the efficacy and safety of a candidate drug in the clinic.


To complete its mission K4DD has set three main objectives:

  • To improve the understanding of drug-target binding kinetics from "test tube" to the human body
  • To develop models, software tools and "off-the-shelf assays" that allow routine drug-target binding kinetics analysis, also in high-throughput mode.
  • To raise awareness of the importance of considering the kinetic aspects of drug-target interactions throughout drug development